The Nigerian stock market yesterday saw continued profit-taking, as the market capitalisation declined by N1.06 trillion driven by the losses in Dangote Cement Plc and 40 others.

Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna (MRNA) to $38 from $70 and keeps an Equal Weight rating on the ...

Analyst Mani Foroohar of Leerink Partners maintained a Sell rating on Moderna (MRNA – Research Report), reducing the price target to ...

These and other issues were the topics of the "2025 Markets & Economy Outlook" webinar Monday with Fidelity Investments.

Moderna is expediting its cost-cutting program and rolling back R&D amid a drop in vaccination rates and low revenues from a new vaccine.

DB Insurance shares closed at 91,700 won on the KOSPI market on the 14th. The stock price fell by 8.12% (8,100 won) from the ...

CNBC's Jim Cramer examined Monday's market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique ...

World stocks have retreated after U.S. stocks fell as good news on the job market raised worries over inflation.

S&P 500 slides 0.6% as Palantir drops 4% and Moderna tumbles 23%. Rising Treasury yields and upcoming CPI data keep traders ...

Moderna Inc. (NYSE: MRNA) has revised its sales projections for 2025, lowering expectations due to sluggish demand for its ...

Moderna’s stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.

Possible sanction tightening on Russian oil sent crude to its highest close in five months in today's trading. February-dated West Texas Intermediate (WTI) crude added $2.25, or 2.9%, to settle $78.82 ...